KPIs & Operating Metrics(New)
Growth Metrics

Abbott Laboratories (ABT) Net Margin (2009 - 2026)

Abbott Laboratories recorded quarterly Net Margin of 9.65% in Q1 2026, down 37.76% quarter-over-quarter from 15.5% in Q4 2025, and down 314.0% year-over-year from 4.51% in Q1 2025.

Abbott Laboratories' Net Margin history runs 18 years deep, the most recent figure standing at 9.65% for Q1 2026.

  • In Q1 2026, Net Margin fell 314.0% year-over-year to 9.65%; the TTM figure through Mar 2026 stood at 13.91% (down 1798.0% YoY), while the FY2025 annual figure was 14.72%, down 1723.0% from the prior year.
  • Net Margin came in at 9.65% for Q1 2026 at Abbott Laboratories, down from 15.5% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 84.1% in Q4 2024 to a low of 9.65% in Q1 2026.
  • A 5-year average of 18.37% and a median of 14.16% in 2023 frame the typical range for Net Margin.
  • Across the five-year window, Net Margin surged 6853 bps in 2024 and plunged 6860 bps in 2025, its largest moves.
  • Abbott Laboratories' Net Margin stood at 10.24% in 2022, then surged by 52 bps to 15.56% in 2023, then soared by 440 bps to 84.1% in 2024, then plunged by 82 bps to 15.5% in 2025, then tumbled by 38 bps to 9.65% in 2026.
  • According to Business Quant data, Net Margin over the past three periods registered 9.65%, 15.5%, and 14.46% for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 9.65%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 12.38%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 12.75%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 25.77%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.00%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 16.74%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 8.01%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn 11.42%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 9.65%
Dec 31, 2025 15.50%
Sep 30, 2025 14.46%
Jun 30, 2025 15.97%
Mar 31, 2025 12.79%
Dec 31, 2024 84.10%
Sep 30, 2024 15.48%
Jun 30, 2024 12.55%
Mar 31, 2024 12.29%
Dec 31, 2023 15.56%
Sep 30, 2023 14.16%
Jun 30, 2023 13.78%
Mar 31, 2023 13.52%
Dec 31, 2022 10.24%
Sep 30, 2022 13.78%
Jun 30, 2022 17.93%
Mar 31, 2022 20.50%
Dec 31, 2021 17.27%
Sep 30, 2021 19.14%
Jun 30, 2021 11.58%
Mar 31, 2021 17.07%
Dec 31, 2020 20.10%
Sep 30, 2020 13.85%
Jun 30, 2020 7.29%
Mar 31, 2020 7.26%
Dec 31, 2019 12.56%
Sep 30, 2019 11.81%
Jun 30, 2019 12.53%
Mar 31, 2019 8.87%
Dec 31, 2018 8.36%
Sep 30, 2018 7.31%
Jun 30, 2018 9.40%
Mar 31, 2018 5.62%
Dec 31, 2017 -10.95%
Sep 30, 2017 8.80%
Jun 30, 2017 4.23%
Mar 31, 2017 6.58%
Dec 31, 2016 14.87%
Sep 30, 2016 -6.21%
Jun 30, 2016 11.48%
Mar 31, 2016 6.45%
Dec 31, 2015 14.75%
Sep 30, 2015 11.20%
Jun 30, 2015 15.09%
Mar 31, 2015 46.58%
Dec 31, 2014 16.80%
Sep 30, 2014 10.55%
Jun 30, 2014 9.16%
Mar 31, 2014 7.84%
Dec 31, 2013 11.53%
Sep 30, 2013 19.96%
Jun 30, 2013 9.59%
Mar 31, 2013 11.16%
Dec 31, 2012 17.89%
Sep 30, 2012 36.90%
Jun 30, 2012 32.46%
Mar 31, 2012 23.51%
Dec 31, 2011 15.60%
Sep 30, 2011 3.09%
Jun 30, 2011 20.20%
Mar 31, 2011 9.55%
Dec 31, 2010 14.46%
Sep 30, 2010 10.27%
Jun 30, 2010 14.63%
Mar 31, 2010 13.03%
Dec 31, 2009 25.84%
Sep 30, 2009 19.07%
Jun 30, 2009 17.19%